10 Sep

HealthBeacon shortlisted as Supplier of the Year to the Pharma Industry

Digital Therapeutics company, HealthBeacon has been short listed in two categories at the Pharma Industry Awards.

The HealthBeacon Smart Sharps Platform has once again been nominated for their outstanding work with global pharmaceutical brands to support injectable medication treatments. HealthBeacon will defend their title of Pharma Project of the Year at the Pharma Industry Awards 2018. This year, HealthBeacon has also been short listed for another important award, Pharma Supplier of the Year. The Supplier of the Year award recognises a company or organisation that has provided a ‘best in class’ service, solution, product or goods to the Pharmaceutical industry. So far in 2018, HealthBeacon has received FDA clearance to enter the USA market, regulatory approval to bring HealthBeacon to Brazil and won multiple awards from the pharmaceutical industry.

Last year, HealthBeacon won the category for Pharma Project of the Year-Large and were shortlisted for Innovation of the Year. Since launching in 2014, the Pharma Industry Awards has established itself as the benchmark for excellence for those operating in Ireland’s pharma industry.

The Pharma Project of the Year award recognises an outstanding project undertaken in Ireland’s Pharma industry over the past 12 months. We believe the HealthBeacon project has received this special recognition due to the scale of the opportunity to impact the pharmaceutical industry. With billions of dollars spent annually, medication adherence is one of the most challenging issues facing the industry today.

The finalists will be present and the winners will be revealed at the gala awards ceremony on October 23rd at the Clayton Hotel Burlington Road, Dublin.

https://www.pharmaawards.ie/shortlist

 

About HealthBeacon

HealthBeacon is a Digital Therapeutics company that develops smart tools for managing medication. HealthBeacon has developed an injectable medication management system that tightly monitors patients digitally, keeping them adherent to their prescription and leveraging real time data to drive clinical intervention. This system has been clinically reviewed, validated by the pharmaceutical industry and has been integrated into patient care programs throughout North America and Europe, delivering valuable data to both the patient and their clinical team.